2023
DOI: 10.1016/j.jaad.2022.12.029
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines of care for the management of atopic dermatitis in adults with topical therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
89
0
2

Year Published

2023
2023
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 85 publications
(91 citation statements)
references
References 101 publications
0
89
0
2
Order By: Relevance
“…Although individual sessions are short, starting with a few seconds and building up to several minutes; most regimens require three sessions weekly for 6 weeks minimum (usually longer). 4 Long-term evidence on the effectiveness of phototherapy in symptom control is lacking, as the studies referenced only followed up patients for 6-12 weeks.…”
Section: Commentarymentioning
confidence: 99%
See 2 more Smart Citations
“…Although individual sessions are short, starting with a few seconds and building up to several minutes; most regimens require three sessions weekly for 6 weeks minimum (usually longer). 4 Long-term evidence on the effectiveness of phototherapy in symptom control is lacking, as the studies referenced only followed up patients for 6-12 weeks.…”
Section: Commentarymentioning
confidence: 99%
“…They include skin sensitivity, erythema, burning, pruritis and herpes simplex reactivation. [4][5][6] There is a risk of skin cancer demonstrated in the use of PUVA for psoriasis; but the risk was not increased with UVA1, BB-UVB and NB-UVB for other indications, mainly psoriasis. 6 There is no evidence comparing phototherapy with other systemic treatments such as ciclosporin, methotrexate or biologics.…”
Section: Commentarymentioning
confidence: 99%
See 1 more Smart Citation
“…Treatments such as topical glucocorticoids (TGCs), immunosuppressive drugs and phototherapy have been used for both diseases. Among them, TGCs have been commonly used to treat mild‐to‐moderate cases of AD and PSO 4‐9 . Although corticosteroids are primarily produced in the adrenal gland, they can also be produced in extra‐adrenal tissues, such as those of the immune system, and the skin, brain and intestine 10 .…”
Section: Introductionmentioning
confidence: 99%
“…Among them, TGCs have been commonly used to treat mild-to-moderate cases of AD and PSO. [4][5][6][7][8][9] Although corticosteroids are primarily produced in the adrenal gland, they can also be produced in extra-adrenal tissues, such as those of the immune system, and the skin, brain and intestine. 10 In the skin, glucocorticoid synthesis begins with cholesterol, and steroidogenesis is regulated in a complex fashion.…”
mentioning
confidence: 99%